Angiotensin converting enzyme (ACE) inhibitory peptides are been extensively studied 31
64 65 3
Introduction 56
Angiotensin I converting enzyme (ACE) is a dipeptidyl carboxypeptidase which plays 57 an essential role as a regulator of blood pressure. ACE converts angiotensin I to the 58 potent vasoconstrictor angiotensin II, which also induces the release of aldosterone. 59
Moreover, ACE inactivates bradykinin, which has vasodilator activity. As a result, the 60 action of ACE on these two systems is responsible for hypertension, the most common 61 In addition, the ACE inhibitory activity of the transported peptides was measured to 99 evaluate their final antihypertensive potential. 100 101
Materials and methods 102

Material and reagents 103
Dulbeco's Modified Eagle's Medium (DMEM), GlutaMAX™, phosphate buffered 104 saline (PBS), and nonessential amino acids were procured from Life Technologies1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 5 (Ghent, Belgium), whereas fetal bovine serum was from Greiner Bio-One (Vilvoorde, 106 Belgium). Angiotensin-converting enzyme (from rabbit lung) was purchased from 107 Sigma Chemical Co. (St. Louis, Mo., USA), and o-aminobenzoylglycyl-p-nitro-L-108 phenylalanyl-L-proline (Abz-Gly-p-nitro-Phe-Pro-OH) trifluoroacetate salt was from 109
Bachem AG. (Bubendorf, Switzerland). Methanol HPLC grade was from Sharlab, S.L. 110 (Barcelona, Spain). All other chemicals and reagents used were of analytical grade. 111
Dry-cured ham extracts and peptides 112
The study was done using extracts from different types of dry-cured ham. Samples M1 113 and S1 were obtained from Spanish dry-cured hams with ten months of processing, 114 which were submitted subjected to extraction and deproteinisation according to the 115 methodology described by Escudero et al. (2012) . In the case of sample S1, the extract 116 was fractionated by gel filtration chromatography using a Sephadex G-25 column (2.5 × 117 65 cm), and fractions corresponding to elution volumes from 200 to 320 mL were 118 pooled together and lyophiliseddried. These fractions were selected because they have 119
shown the maximum ACE inhibitory activity, reaching values of 80% of inhibition in a 120 previous study (Escudero et al., 2012) . In addition, Designation of Origin of Teruel 121 hams with a minimum time of ripening of fourteen months were used to obtain samples 122 M2 and M3. Peptide extraction was done according to the method described by 123 Escudero et al. (2014) for sample M2, while sample M3 was submitted subjected to 124 extraction and deproteinisation following the same procedure as described above for 125 sample M1 and S1. All dry-cured ham extracts were desalted by solid phase extraction 126 using an Oasis ® hydrophilic-lipophilic balance (HLB) cartridge (35 cc, Waters, Ireland), 127 where peptides were retained and then eluted with 50% methanol. Finally, the eluates 128 were lyophilised for the transport experiment across Caco-2 cells. Precision Instruments, Hertfordshire, UK) was higher than 300 Ω*cm². 153 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 7 Differentiated Caco-2 cells were gently rinsed twice with PBS and then incubated with 155 PBS for 1 day at 37 °ºC in 10% CO 2 prior to the transport assays. After removing the 156 PBS from all wells, 1 mg/mL of the samples dissolved in PBS were was added to the 157 apical chambers (200 µL), whereas fresh PBS was added to the basolateral chambers (1 158 mL). A control sample, containing only PBS and no peptides, was included in the 159 experimental setup, and samples from apical and basolateral sides were taken before (0 160 min) and during incubation at different time points of 15, 30, and 60 min. The action of 161 cell proteases on samples after the transport study was immediately stopped by adding 9 162 volumes of methanol, centrifuged at 7500g for 10 min, and finally the supernatant 163 containing the peptides was taken and dried for the following analysis. All experiments 164
Transport studies
were conducted done in triplicate. 165
ACE inhibitory activity 166
Apical and basal samples taken from the transepithelial transport at different times were 167 analysed for ACE inhibitory activity. For this purpose, dried apical samples were 168 dissolved to the original volume in bidistilled water, whereas dried basal samples were 169 first dissolved in a volume four-fold smaller than the original one to determine the ACE 170 inhibition in concentrated samples, and then redissolved diluted to the original volume 171 to test again. Basal samples were concentrated in order to be comparable in terms of 172 peptide concentration with apical samples. Additionally, the ACE inhibitory activity of 173 several synthetised fragments derived from the degradation of AAATP, AAPLAP, and 174 KPVAAP through the cellular transport was evaluated. In all studied cases, tThe ACE 175 inhibitory activity was measured according to the method developed by Sentandreu and 176 Toldrá (2006), which is based on the ability of ACE to hydrolyse the internally 177
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ACE inhibitory activity of samples taken from transport assays 237
Dry-cured ham extracts and peptide solutions taken from the apical and basal 238 compartments at different transport times were analysed for ACE inhibitory activity , 239 directly after sampling and in basal samples also after concentrating four times (Figure  240 2). In the case of dry-cured ham extracts, sSamples taken from the apical side showed 241 high ACE inhibition, generally reaching the maximum values at 15 min of cellular 242 transport except for sample S1, which presented slightly higher ACE inhibition before 243 incubation than during the cellular assay. in both types of samples, and with values very 244 close to 100% inhibition for the purified peptides. These high inhibition values at 15 245 min of the transport may be due to a strong action of cell peptidases on these peptides at 246 this time, whereby the modification of the peptide structure may affect its biological 247 activity and peptide fragments released can show even a higher degree of ACE 248 inhibitory activity compared toin comparison with the precursor peptides (Miguel, 249 Recio, Gómez-Ruiz, Ramos, & López- Fandiño, 2004 ). In fact, In the case of dry-cured 250 ham samples, samples M1 and S1 showed similar inhibition results even though sample 251 S1 contained only the fractions which showing the highest ACE inhibitory activity. 252
Meanwhile, the activity decreases more significantly after 30 min of transport for 253 samples M2 and M3, which come from dry-cured hams with longer curing process. The1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 11 ACE inhibition activity for sample M2 before the transport assay was very low (with a 255 value of 4.5%), which is in agreement with a previous study (Escudero et al., 2014) , and 256 which that is probably due owing to this sample has not been deproteinised compared 257 toin comparison with sample M3. Additionally, sample M2 did not show any ACE 258 inhibitory activity in the apical side after 60 min of cellular transport, indicating that 259 inhibitory peptides were either completely hydrolysed or transported to the basal side. 260
On the other hand, little to no ACE inhibition was detected in the basal samples, so 
Peptide degradation by epithelial peptidases 291
As dry-cured ham samples contain a very complex mixture of peptides, only the 292 degradation of the purified peptides on the brush-border side was evaluated by MS-293 based techniques in order to detect those peptides that were transcellularly transported. 294 Table 1 shows the peptide sequences detected by MALDI-ToF/ToF MS in the apical 295 and basal compartments at the different assayed times. 296
The analysis revealed the degradation of the intact peptide AAATP after 15 min of 297 transport with and the generation of smaller sized peptides, some of which can could 298 cross the intestinal barrier up to the basal side. On the other hand, AAPLAP was 299 detected in the apical chamber throughout the experiment, but analysis of the basal 300 solutions showed that it was not transported intact. In fact, several shorter fragments 301 were also detected in the apical and basal solutions, suggesting its partial degradation by 302 brush border peptidases. Furthermore, peptide KPVAAP was detected up to 60 min of 303 transport in both apical and basal samples, indicating that its chemical and structural 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65   13 properties allow it to be absorbed intact through the Caco-2 monolayer. However, it was 305 also susceptible to peptidases and different derived fragments were also detected in 306 apical and basal solutions. In this senseregard, among all the fragments detected in 307 either apical or basal samples, several of them were previously reported as ACE 308 inhibitory peptides (Table 1 of The study done by Escudero et al. (2013) showed in vivo ACE inhibitory activity for the 326 peptide AAATP, although according to the present study it is not absorbed intact 327 through the intestinal barrier (Table 1) . These results suggest that either the fragments 328 derived from its degradation are responsible for the decrease in blood pressure in the 329 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 Table 1 of Supplementa a Possible fragments derived from the degradation of the precursor peptide.
b Monoisotopic molecular mass in Daltons of the matched peptide.
c Peptides detected in the apical compartment at different transport times.
d Peptides detected in the basal compartment at different transport times. 
